Skip to main content
PMC home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1965 Feb;24(1):253–265. doi: 10.1111/j.1476-5381.1965.tb02101.x

Some factors influencing the recovery of isolated myocardium from acute anoxia

R G Penn
PMCID: PMC1704052  PMID: 14302359

Full text

PDF
258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELROD J., HERTTING G., PATRICK R. W. Inhibition of H3-norepinephrine release by monoamine oxidase inhibitors. J Pharmacol Exp Ther. 1961 Dec;134:325–328. [PubMed] [Google Scholar]
  2. BAGDONAS A. A., STUCKEY J. H., PIERA J., AMER N. S., HOFFMAN B. F. Effects of ischemia and hypoxia on the specialized conducting system of the canine heart. Am Heart J. 1961 Feb;61:206–218. doi: 10.1016/0002-8703(61)90577-4. [DOI] [PubMed] [Google Scholar]
  3. BAKER J. B. E. An improved apparatus for mammalian heart perfusion. J Physiol. 1951 Sep;115(1):30–2P. [PubMed] [Google Scholar]
  4. BELFORD J., FEINLEIB M. R. The increase in glucose-6-phosphate content of the heart after the administration of inotropic catecholamines, calcium, and aminophylline. Biochem Pharmacol. 1962 Nov;11:987–994. doi: 10.1016/0006-2952(62)90157-0. [DOI] [PubMed] [Google Scholar]
  5. BURN J. H., RAND M. J. Excitatory action of the vagus in the isolated atria in relation to adrenaline. J Physiol. 1958 Jun 18;142(1):173–186. doi: 10.1113/jphysiol.1958.sp006007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COFFMAN J. D., GREGG D. E. Oxygen metabolism and oxygen debt repayment after myocardial ischemia. Am J Physiol. 1961 Nov;201:881–887. doi: 10.1152/ajplegacy.1961.201.5.881. [DOI] [PubMed] [Google Scholar]
  7. COFFMAN J. D., LEWIS F. B., GREGG D. E. Effect of prolonged periods of anoxia on atrioventricular conduction and cardiac muscle. Circ Res. 1960 May;8:649–659. doi: 10.1161/01.res.8.3.649. [DOI] [PubMed] [Google Scholar]
  8. CRISLIP R. L., MENGES H., Jr, POPOVICH N. R., ROBERTS F. F. Ineffectiveness of nitroglycerin as an antiadrenergic agent on the cat heart. Circ Res. 1956 Nov;4(6):727–730. doi: 10.1161/01.res.4.6.727. [DOI] [PubMed] [Google Scholar]
  9. DARBY T. D., ALDINGER E. E. Further studies of the effects on myocardial energy utilization elicited by nitroglycerin. Circ Res. 1960 Jan;8:100–108. doi: 10.1161/01.res.8.1.100. [DOI] [PubMed] [Google Scholar]
  10. ECKSTEIN R. W., NEWBERRY W. B., McEACHEN J. A., SMITH G. Studies of the antiadrenergic effects of nitroglycerin on the dog heart. Circulation. 1951 Oct;4(4):534–540. doi: 10.1161/01.cir.4.4.534. [DOI] [PubMed] [Google Scholar]
  11. FAWAZ G., TUTUNJI B. The effect of adrenaline and noradrenaline on the metabolism and performance of the isolated dog heart. Br J Pharmacol Chemother. 1960 Sep;15:389–395. doi: 10.1111/j.1476-5381.1960.tb01261.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GARB S., PENNA M., GANZ A. Effects of epinephrine, norepinephrine and isopropylarterenol on the isolated auricles of four mammalian species. Am J Physiol. 1956 May;185(2):332–336. doi: 10.1152/ajplegacy.1956.185.2.332. [DOI] [PubMed] [Google Scholar]
  13. GARDNER E. A., FARAH A. The action of some enzyme inhibitors on the isolated rabbit auricle. J Pharmacol Exp Ther. 1954 Jul;111(3):255–264. [PubMed] [Google Scholar]
  14. GORLIN R., BRACHFELD N., MACLEOD C., BOPP P. Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work. Circulation. 1959 May;19(5):705–718. doi: 10.1161/01.cir.19.5.705. [DOI] [PubMed] [Google Scholar]
  15. HESS M. E., SHANFELD J., HAUGAARD N. The effect of epinephrine on isometric tension and phosphorylase activity of the isolated rat heart. Biochem Pharmacol. 1962 Nov;11:1031–1034. doi: 10.1016/0006-2952(62)90161-2. [DOI] [PubMed] [Google Scholar]
  16. HONIG C. R., TENNEY S. M., GABEL P. V. The mechanism of cardiovascular action of nitroglycerine. An example of integrated response during the unsteady state. Am J Med. 1960 Dec;29:910–923. doi: 10.1016/0002-9343(60)90073-5. [DOI] [PubMed] [Google Scholar]
  17. KINSELLA D., TROUP W., McGREGOR M. Studies with a new coronary vasodilator drug: persantin. Am Heart J. 1962 Feb;63:146–151. doi: 10.1016/0002-8703(62)90190-4. [DOI] [PubMed] [Google Scholar]
  18. LAUDAHN G. [The effect of Persantin on heart muscle sarcosomes]. Experientia. 1961 Sep 15;17:415–416. doi: 10.1007/BF02157978. [DOI] [PubMed] [Google Scholar]
  19. OLSON R. E., SCHWARTZ W. B. Myocardial metabolism in congestive heart failure. Medicine (Baltimore) 1951 Feb;30(1):21–41. doi: 10.1097/00005792-195102000-00002. [DOI] [PubMed] [Google Scholar]
  20. PLETSCHER A. [Monoamino-oxidase inhibitors]. Dtsch Med Wochenschr. 1961 Apr 7;86:647–657. doi: 10.1055/s-0028-1112838. [DOI] [PubMed] [Google Scholar]
  21. SETNIKAR I., RAVASI M. T. Increase in resistance of the heart to anoxia by iproniazid. Arch Int Pharmacodyn Ther. 1960 Feb 1;124:116–122. [PubMed] [Google Scholar]
  22. WEBB J. L. The actions of metabolic substrates and inhibitors on the rabbit auricle. Br J Pharmacol Chemother. 1950 Mar;5(1):87–117. doi: 10.1111/j.1476-5381.1950.tb00580.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WEST J. W., BELLET S., MANZOLI U. C., MUELLER O. F. Effects of Persantin (RA8), a new coronary vasodilator, on coronary blood flow and cardiac dynamics in the dog. Circ Res. 1962 Jan;10:35–44. doi: 10.1161/01.res.10.1.35. [DOI] [PubMed] [Google Scholar]
  24. WITHRINGTON P., ZAIMIS E. The reserpine-treated cat. Br J Pharmacol Chemother. 1961 Dec;17:380–391. doi: 10.1111/j.1476-5381.1961.tb01124.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. YANG W. C. ANAEROBIC FUNCTIONAL ACTIVITY OF ISOLATED RABBIT ATRIA. Am J Physiol. 1963 Oct;205:781–784. doi: 10.1152/ajplegacy.1963.205.4.781. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES